About this trial
This randomized controlled trial compares a video laryngeal mask airway (VLMA) and an endotracheal tube (ETT) in adult patients undergoing elective septoplasty. The primary objective is to see which device more effectively prevents surgical blood contamination in the glottic and subglottic regions. The study also assesses perioperative hemodynamic stability, ventilation parameters, and postoperative recovery factors such as sore throat, hoarseness, and overall patient comfort. The findings aim to help determine the optimal airway device choice for nasal surgeries.
Eligibility criteria
Qualifiers
ASA I-II classification patients
Patients aged 18-65 years undergoing elective septoplasty
Disqualifiers
ASA III-IV classification patients
Patients with anticipated difficult airway
Patients under 18 years of age
History of gastroesophageal reflux disease (GERD) or hiatal hernia
Trial design
Treatments tested in this trial
- Video Laryngeal Mask Airway (VLMA)
- Endotracheal Tube (ETT)